Mutational Profile and Prognostic Significance of TP53 in Diffuse Large B-cell Lymphoma Patients Treated with Rituximab-CHOP: A Report From an International DLBCL Rituximab-CHOP Consortium Program Study
Titel:
Mutational Profile and Prognostic Significance of TP53 in Diffuse Large B-cell Lymphoma Patients Treated with Rituximab-CHOP: A Report From an International DLBCL Rituximab-CHOP Consortium Program Study
Auteur:
Xu-Monette, Zijun Y. Wu, Lin Visco, Carlo Tai, Yu Chuan Tzankov, Alexander Liu, Wei-min Montes-Moreno, Santiago Dybkær, Karen Chiu, April Orazi, Attilio Zu, Youli Bhagat, Govind Richards, Kristy L. Hsi, Eric D. Zhao, X. Frank Choi, William W.L. Zhao, Xiaoying van Krieken, J. Han Huang, Qin Huh, Jooryung Ai, Weiyun Ponzoni, Maurilio Ferreri, Andrés J.M. Zhou, Fan Kahl, Brad S. Winter, Jane N. Xu, Wei Li, Jianyong Go, Ronald S. Li, Yong Piris, Miguel A. Møller, Michael B. Miranda, Roberto N. Abruzzo, Lynne V. Medeiros, L. Jeffrey Young, Ken H.